| IBC's 10th Annual World Congress DRUG DISCOVERY TECHNOLOGY AND DEVELOPMENT 2005 Boston, MA, USA August 8-11, 2005 | 2006/06/07 | English | |
| Hypertension, Hyperlipidemia and Stroke. Utilizing Evidence to Improve Outcome New York Academy of Medicine Symposium May 17–18, 2004 | 2004/09/01 | English | |
| Acknowledgment of Reviewers | 1999/12/01 | English | |
| Advances in Anticoagulant, Antithrombotic, and Thrombolytic Drugs: 10th Anniversary International Symposium, October 3–7, 1999 | 1999/12/01 | English | |
| Sixteenth Annual Meeting of the American Society for Hypertension San Francisco, CA, USA May 15–19, 2001 | 2001/09/01 | English | |
| Seventeenth Annual Meeting of American Society of Hypertension, New York, NY, May 14–18, 2002 Renin 2002: The Laragh Method for Treating Hypertension and Its Consequences | 2002/09/01 | English | |
| Cardiovascular Pharmacological Characteristics of S‐2150: A Novel Dual Blocker of Calcium Channels and α1‐Adrenoceptors | 1997/12/01 | English | |
| Myocardial Protection by Monophosphoryl Lipid A: Potential Mechanisms | 1999/09/01 | English | |
| ACKNOWLEDGMENT OF REVIEWERS | 2007/12/01 | English | |
| Ion Channels in Drug Discovery and Development Princeton, NJ, USA May 20–21, 2002 | 2002/09/01 | English | |
| XIVth World Congress of Pharmacology San Francisco, CA, July 7–12, 2002 New Cardiovascular Drugs | 2002/09/01 | English | |
| STROKE: From Bench to Bedside ASPET‐Ray Fuller Symposium San Diego Marriott Hotel, San Diego, CA, USA April 10 – 11, 2003 | 2003/09/01 | English | |
| MCI‐154: A Second Generation Ca2+ Sensitizer That Does Not Impair Relaxation — A Novel Approach to the Treatment of Heart Failure | 2000/12/01 | English | |
| Remembrance | 2002/12/01 | English | |
| Prenalterol | 1984/03/01 | English | |
| Adenosine Receptors as Targets for Drug Discovery. National (215th) Meeting of American Chemical Society, Dallas, TX, March 29 to April 2, 1998. | 1998/06/01 | English | |
| The Ninth International Symposium on Vascular Neuroeffector Mechanisms. Porto, Portugal, August 2–5, 1998. Satellite Symposium of the 13th International Congress of Pharmacology. München, Germany, July 26–31, 1998 | 1998/12/01 | English | |
| Pharmacology of ICI 206,970: A Novel Eukalemic Diuretic with Calcium Channel Blocking Activity | 1994/12/01 | English | |
| Abstracts from the Workshop on Ca2+ Antagonists in Atherosclerosis Sponsored by Miles Institute for Preclinical Pharmacology, Miles, Inc., West Haven, Connecticut, and Institute for Pharmacology, Bayer AG, Wuppertal, F.R.G. Held in Philadelphia, Pennsylvania, October 28 and 29, 1988 | 1988/12/01 | English | |
| SCH 31846 | 1985/03/01 | English | |
| Carteolol | 1986/03/01 | English | |
| 1989 Meetings Calendar | 1989/03/01 | English | |
| Meeting Report | 1989/03/01 | English | |
| New Cardiovascular Drugs, XIIIth International Congress of Pharmacology, Munich, Germany, July 26–31, 1998 | 1998/09/01 | English | |
| Bethanidine Sulfate as an Antifibrillatory Drug | 1983/03/01 | English | |
| Cardiovascular Drugs and FDA Regulations | 1983/03/01 | English | |
| Indapamide | 1983/03/01 | English | |
| Professor Michael J. Brody | 1991/03/01 | English | |
| Cardiovascular Effects of AN‐132, a New Diamine Analogue of Lidocaine | 1991/03/01 | English | |
| A Stable Prostacyclin Analogue, 9β‐Methylcarbacyclin (U‐61,431F) | 1992/06/01 | English | |